SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (21718)5/7/1999 4:33:00 PM
From: DAVID  Read Replies (1) | Respond to of 23519
 
<<. I think the most important subject along those lines is the female SD product. Also we don't really know what is going on on the domestic partnership front.>>

Vlad,

The above ARE the 'money' questions. Is AZ going to partner with us ? We should know something by the June stockholders meeting. What is the projected timetable for the female cream ? That question should be asked in the stockholders meeting.

DAVID



To: VLAD who wrote (21718)5/7/1999 4:54:00 PM
From: DAVID  Read Replies (1) | Respond to of 23519
 
Vlad,

I feel that before a 'large' company would buy out Vivus two things need to happen:

1) Alibra approved for market by the FDA.
2) The female cream shows that it is effective with 'substantially' good results as demonstrated by a quality clinition.

When these things happen, Vivus will be a good prospect. Of course, international sales expand and maybe a domestic partner is also found.

DAVID


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News